I find Scilife to be user-friendly. I also appreciate the sophisticated validation done on the system, especially its compliance with GXP and 21 CFR part 11.

A lot of growing life sciences companies delay implementing an eQMS because they assume it will be expensive, painfully complex, and designed only for big pharma. Scilife is one of the few platforms that genuinely breaks that perception. What impressed us is how accessible and scalable the system feels for smaller and mid-sized biotech teams that need structure and inspection readiness without a massive enterprise burden. The implementation is pragmatic, the user adoption is far easier than expected, and the platform avoids the heavy, overly engineered feel that many larger systems create. In practice, we’ve found it gives companies a far more realistic route into digital quality management than platforms like Veeva, particularly for organisations still building operational maturity.

The system is user friendly and contains many different modules and has been well adopted internally.